Gout Flares - Rilonacept Effective, According To Clinical Trial
According to a phase II clinical trial, the drug rilonacept, which inhibits the protein interleukin-1 (IL-1), substantially reduces acute gout flares that occur at the start of uric acid-reducing therapy and is noted to be generally well tolerated with no serious infections or serious adverse events occurring in relation to the treatment. The findings of the first placebo controlled study, in ...
TUESDAY, Jan. 24 (HealthDay News) -- If you have gout, drinking enriched skim milk may help reduce the frequency of painful flare-ups, new research suggests.
An early-career rheumatology researcher who has already made significant contributions to improving the treatment of arthritis and gout is the University of Otago's latest Rowheath Trust Award and Carl Smith Medal recipient.